Review



high-affinity choline transporter (slc5a7/cht1) antibody  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher high-affinity choline transporter (slc5a7/cht1) antibody
    High Affinity Choline Transporter (Slc5a7/Cht1) Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/cht1+antibody/pm37827341-89-41-46
    Average 90 stars, based on 1 article reviews
    high-affinity choline transporter (slc5a7/cht1) antibody - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Activation of the High-Affinity Choline Transporter 1 in the Spinal Cord Relieves Stress-Induced Hyperalgesia.
    Article Snippet: Background The mechanism underlying irritable bowel syndrome (IBS), a common disease with hyperalgesia, remains elusive.. The spinal cholinergic system is involved in pain modulation, but its role in IBS is unknown.. Aims To determine whether high-affinity choline transporter 1 (CHT1, a major determinant of the cholinergic signaling capacity), is implicated in spinal modulation of stress-induced hyperalgesia.

    Article Title: CDP-choline modulates cholinergic signaling and gut microbiota to alleviate DSS-induced inflammatory bowel disease.
    Article Snippet: The membranes were sealed (20 °C, 12 min) in protein-free rapid blocking buffer (EpiZyme, PS108P, China) and incubated overnight at 4 °C in the following primary antibody: β-Actin (1:1000, Cell Signaling Technology, #3700, USA), Occludin (1:1000, Cell Signaling Technology, #91131, USA), High-affinity choline transporter (SLC5A7/ChT1 1:1000, ThermoFisher, PA5-42485, USA), Choline acetyltransferase (ChAT, 1:1000, Cell Signaling Technology, #27269, USA), Acetylcholinesterase (AChE, 1:1500, Abcam, ab183591, UK), Vesicular acetylcholine transporter (SLC18A3/VAChT, 1:1000, Boster Bio, A04891, China), α7 nicotinic acetylcholine receptor (CHRNA7/α7 nAChR, 1:1000, Proteintech, 21379–1-AP, China), Tumor necrosis factor-α (TNF-α, 1:1000, Cell Signaling Technology, #11948, USA), Interleukin 6 (IL-6, 1:1000, HUABIO, R1412-2, China) and ZO-1 (1:1500, Bioswamp, PAB36669, China).

    Article Title: Biochemical characterization of two novel mutations in the human high-affinity choline transporter 1 identified in a patient with congenital myasthenic syndrome.
    Article Snippet: Congenital myasthenic syndrome (CMS) is a heterogeneous condition associated with 34 different genes, including SLC5A7, which encodes the high-affinity choline transporter 1 (CHT1).. CHT1 is expressed in presynaptic neurons of the neuromuscular junction where it uses the inward sodium gradient to reuptake choline.. Biallelic CHT1 mutations often lead to neonatal lethality, and less commonly to non-lethal motor weakness and developmental delays.

    Real-time Polymerase Chain Reaction:

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_ m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Article Title: Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
    Article Snippet: The integrity of the extracted RNA was confirmed with Bioanalyzer (Agilent, Palo Alto, CA, USA). .. Reverse transcription was performed using 300 ng of total RNA with a TaqMan reverse transcription kit (Applied Biosystems, Perkin-Elmer Corporation, CA, USA). cDNA was amplified using specific primers together with probes predesigned by Applied Biosystems for organic transporter cation 1 (OTC1; cat. no. Hs00222691_m1), OTC2 (cat. no. Hs01010726_m1), OTC3 (cat. no. Hs00427552_m1), choline acetyltransferase (ChAT; cat. no. Hs00252848_m1), high-affinity choline transporter (ChT1; cat. no. Hs00222367_m1), M1 (cat. no. Hs00265195_s1), M2 (cat. no. Hs00265208_s1), M3 (cat. no. Hs00265216_s1), M4 (cat. no. Hs00265219_s1), M5 (cat. no. Hs00255278_s1), β2 adrenergic receptor (β2ADR; cat. no. Hs00240532_s1), vesicular acetylcholine transporter (cat. no. VAChT; Hs00268179_s1), macrophage migration inhibitory factor (MIF; cat. no. Hs00236988), mitogen-activated protein kinase phosphatase 1 (MKP-1; cat. no. Hs00610256), PI3K-δ (cat. no. Hs00192399), HDAC2 (cat. no. Hs00231032), GRα (cat. no. Hs00353740_m1), cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2; cat. no. Hs00230322_m1) and glucocorticoid-induced leucine zipper (GILZ; cat. no. Hs00608272_m1) genes in a 7900HT Fast Real-Time PCR system (Applied Biosystems) using Universal Master Mix (Applied Biosystems). .. Expression of the target gene was reported as the fold increase or decrease relative to the expression of GAPDH as an endogenous control (Applied Biosystems; 4310884E).

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL-22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Amplification:

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_ m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Article Title: Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
    Article Snippet: The integrity of the extracted RNA was confirmed with Bioanalyzer (Agilent, Palo Alto, CA, USA). .. Reverse transcription was performed using 300 ng of total RNA with a TaqMan reverse transcription kit (Applied Biosystems, Perkin-Elmer Corporation, CA, USA). cDNA was amplified using specific primers together with probes predesigned by Applied Biosystems for organic transporter cation 1 (OTC1; cat. no. Hs00222691_m1), OTC2 (cat. no. Hs01010726_m1), OTC3 (cat. no. Hs00427552_m1), choline acetyltransferase (ChAT; cat. no. Hs00252848_m1), high-affinity choline transporter (ChT1; cat. no. Hs00222367_m1), M1 (cat. no. Hs00265195_s1), M2 (cat. no. Hs00265208_s1), M3 (cat. no. Hs00265216_s1), M4 (cat. no. Hs00265219_s1), M5 (cat. no. Hs00255278_s1), β2 adrenergic receptor (β2ADR; cat. no. Hs00240532_s1), vesicular acetylcholine transporter (cat. no. VAChT; Hs00268179_s1), macrophage migration inhibitory factor (MIF; cat. no. Hs00236988), mitogen-activated protein kinase phosphatase 1 (MKP-1; cat. no. Hs00610256), PI3K-δ (cat. no. Hs00192399), HDAC2 (cat. no. Hs00231032), GRα (cat. no. Hs00353740_m1), cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2; cat. no. Hs00230322_m1) and glucocorticoid-induced leucine zipper (GILZ; cat. no. Hs00608272_m1) genes in a 7900HT Fast Real-Time PCR system (Applied Biosystems) using Universal Master Mix (Applied Biosystems). .. Expression of the target gene was reported as the fold increase or decrease relative to the expression of GAPDH as an endogenous control (Applied Biosystems; 4310884E).

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL-22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Expressing:

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_ m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL-22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Control:

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_ m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL-22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Gene Expression:

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_ m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Article Title: Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells.
    Article Snippet: In this study, we examined the molecular and functional characterization of choline transporter in human brain microvascular endothelial cells (hBMECs).. Choline uptake into hBMECs was a saturable process that was mediated by a Naþ-independent, membrane potential and pH-dependent transport system.. The cells have two different [3H]choline transport systems with Km values of 35.0 ± 4.9 mM and 54.1 ± 8.1 mM, respectively.

    Article Title: Protein kinase C promotes choline transporter-like protein 1 function via improved cell surface expression in immortalized human hepatic cells
    Article Snippet: Total RNA was extracted from the cells using a QIAshredder and RNeasy Mini kit (Qiagen Inc.) according to the manufacturer's instructions. .. TaqMan probes for target mRNAs (CHT1, OCT1-3, CTL1-5, and the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase [ GAPDH ]) were designed based on its human mRNA sequence using TaqMan Gene Expression Assays (Applied Biosystems; Thermo Fisher Scientific, Inc.). ..

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL-22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Polymerase Chain Reaction:

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_ m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Article Title: Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
    Article Snippet: Genomic DNA was eliminated by treatment with DNase 1 (Qiagen), and 100 ng purified RNA was reverse transcribed into first-strand cDNA using the CellScript cDNA Synthesis Master Mix (CellSafe, Suwon, Korea), which includes a genomic DNA elimination step. .. Real-time PCR amplification and relative expression quantification of IL-12, IL-2, IFN-γ, IL-23, IL-17A, IL-22, and GAPDH as a control were performed by TaqMan gene expression assays (Applied Biosystems, Foster City, CA, USA; Assay ID: CHT1, Hs01011518_m1, Hs00174114_m1, Hs00174143_m1, Hs00372324_m1, Hs00174383_m1, Hs01574154_m1, Hs99999905_m1) on the Lightcycler 480 PCR system (Roche, Mannheim, Germany). ..

    Reverse Transcription:

    Article Title: Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
    Article Snippet: The integrity of the extracted RNA was confirmed with Bioanalyzer (Agilent, Palo Alto, CA, USA). .. Reverse transcription was performed using 300 ng of total RNA with a TaqMan reverse transcription kit (Applied Biosystems, Perkin-Elmer Corporation, CA, USA). cDNA was amplified using specific primers together with probes predesigned by Applied Biosystems for organic transporter cation 1 (OTC1; cat. no. Hs00222691_m1), OTC2 (cat. no. Hs01010726_m1), OTC3 (cat. no. Hs00427552_m1), choline acetyltransferase (ChAT; cat. no. Hs00252848_m1), high-affinity choline transporter (ChT1; cat. no. Hs00222367_m1), M1 (cat. no. Hs00265195_s1), M2 (cat. no. Hs00265208_s1), M3 (cat. no. Hs00265216_s1), M4 (cat. no. Hs00265219_s1), M5 (cat. no. Hs00255278_s1), β2 adrenergic receptor (β2ADR; cat. no. Hs00240532_s1), vesicular acetylcholine transporter (cat. no. VAChT; Hs00268179_s1), macrophage migration inhibitory factor (MIF; cat. no. Hs00236988), mitogen-activated protein kinase phosphatase 1 (MKP-1; cat. no. Hs00610256), PI3K-δ (cat. no. Hs00192399), HDAC2 (cat. no. Hs00231032), GRα (cat. no. Hs00353740_m1), cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2; cat. no. Hs00230322_m1) and glucocorticoid-induced leucine zipper (GILZ; cat. no. Hs00608272_m1) genes in a 7900HT Fast Real-Time PCR system (Applied Biosystems) using Universal Master Mix (Applied Biosystems). .. Expression of the target gene was reported as the fold increase or decrease relative to the expression of GAPDH as an endogenous control (Applied Biosystems; 4310884E).

    Migration:

    Article Title: Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
    Article Snippet: The integrity of the extracted RNA was confirmed with Bioanalyzer (Agilent, Palo Alto, CA, USA). .. Reverse transcription was performed using 300 ng of total RNA with a TaqMan reverse transcription kit (Applied Biosystems, Perkin-Elmer Corporation, CA, USA). cDNA was amplified using specific primers together with probes predesigned by Applied Biosystems for organic transporter cation 1 (OTC1; cat. no. Hs00222691_m1), OTC2 (cat. no. Hs01010726_m1), OTC3 (cat. no. Hs00427552_m1), choline acetyltransferase (ChAT; cat. no. Hs00252848_m1), high-affinity choline transporter (ChT1; cat. no. Hs00222367_m1), M1 (cat. no. Hs00265195_s1), M2 (cat. no. Hs00265208_s1), M3 (cat. no. Hs00265216_s1), M4 (cat. no. Hs00265219_s1), M5 (cat. no. Hs00255278_s1), β2 adrenergic receptor (β2ADR; cat. no. Hs00240532_s1), vesicular acetylcholine transporter (cat. no. VAChT; Hs00268179_s1), macrophage migration inhibitory factor (MIF; cat. no. Hs00236988), mitogen-activated protein kinase phosphatase 1 (MKP-1; cat. no. Hs00610256), PI3K-δ (cat. no. Hs00192399), HDAC2 (cat. no. Hs00231032), GRα (cat. no. Hs00353740_m1), cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2; cat. no. Hs00230322_m1) and glucocorticoid-induced leucine zipper (GILZ; cat. no. Hs00608272_m1) genes in a 7900HT Fast Real-Time PCR system (Applied Biosystems) using Universal Master Mix (Applied Biosystems). .. Expression of the target gene was reported as the fold increase or decrease relative to the expression of GAPDH as an endogenous control (Applied Biosystems; 4310884E).

    Sequencing:

    Article Title: Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells.
    Article Snippet: In this study, we examined the molecular and functional characterization of choline transporter in human brain microvascular endothelial cells (hBMECs).. Choline uptake into hBMECs was a saturable process that was mediated by a Naþ-independent, membrane potential and pH-dependent transport system.. The cells have two different [3H]choline transport systems with Km values of 35.0 ± 4.9 mM and 54.1 ± 8.1 mM, respectively.

    Article Title: Protein kinase C promotes choline transporter-like protein 1 function via improved cell surface expression in immortalized human hepatic cells
    Article Snippet: Total RNA was extracted from the cells using a QIAshredder and RNeasy Mini kit (Qiagen Inc.) according to the manufacturer's instructions. .. TaqMan probes for target mRNAs (CHT1, OCT1-3, CTL1-5, and the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase [ GAPDH ]) were designed based on its human mRNA sequence using TaqMan Gene Expression Assays (Applied Biosystems; Thermo Fisher Scientific, Inc.). ..



    Similar Products

    93
    Proteintech choline transporter 1
    Choline Transporter 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/CHT1+Antibody/pmc12271746-42-29-45
    Average 93 stars, based on 1 article reviews
    choline transporter 1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    GlpBio Technology Inc cht1 protein
    Cht1 Protein, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/cht1+protein/pm39657660-471-19-8
    Average 90 stars, based on 1 article reviews
    cht1 protein - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology type cht1
    Fig. 1 Radioactive choline uptake assay of human <t>CHT1</t> expressed in HEK293 cells. a Radioactive choline uptake of the CHT1-expressing HEK293 cells <t>(wild-type,</t> blue bar) as compared to the background radioactivity from the control cells transfected with the empty vector (EV, gray bar) 10 min after adding 0.1 mM choline with 10% of [3H]-choline. The inhibition of CHT1-mediated choline uptake was measured at 0.1 mM HC3 or 1 mM ML352. Data are mean ± SEM (n = 3 independent experiments). One-way ANOVA; ****P ≤0.0001. b Concentration- dependent choline uptake. Data points are mean ± SEM (n = 3 independent experiments) and fitted to the Michaelis–Menten equation with KM = 3.86 ± 0.68 mM. c Na+ and Cl–-dependent choline uptake. Data are mean ± SEM (n = 4 independent experiments) and are normalized against the radioactivity measurement with NaCl in the reaction solution. One-way ANOVA; ****P ≤0.0001. d, e Concentration-dependent inhibition of CHT1-mediated choline uptake by HC3 (d) and ML352 (e). Data points are mean ± SEM (n = 3 for HC3 and n = 3–6 for ML352) and fitted to the three-parameter dose–response curves (GraphPad Prism 9) with IC50 of 4.98 ± 1.04 nM for HC3 and 168.6 ± 49.4 nM for ML352.
    Type Cht1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/CHT1+Antibody/pm39587078-232-21-45
    Average 93 stars, based on 1 article reviews
    type cht1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc cht1
    The expression levels of cholinergic‐related proteins in the basal forebrain and hippocampus. (A–E) The expression levels of vAchT (A), <t>ChT1</t> (B), AchE (C), m1AchR (D), and m2AchR (E) in the basal forebrain after EA intervention. (F‐J) The expression levels of vAchT (F), ChT1 (G), AchE (H), m1AchR (I), and m2AchR (J) in the hippocampus after EA intervention ( n = 6 for each group, ** p < 0.01/*** p < 0.001 vs WT group, # p < 0.05/## p < 0.01/### p < 0.001 vs AD group, && p < 0.01 vs EA group). (K) Greyscale image of proteins. vAchT, vesicular acetylcholine transporter; ChT1, Choline transporter; AchE, enzyme acetylcholinesterase; m1AchR, Type‐1 muscarinic Acetylcholine receptor; m2AchR, Type‐2 muscarinic Acetylcholine receptor.
    Cht1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/pmc11112630-107-75-79
    Average 86 stars, based on 1 article reviews
    cht1 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Proteintech slc5a7
    Figure 7. CircFBXW4 regulates <t>SLC5A7</t> expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.
    Slc5a7, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/CHT1+Antibody/pm38461489-427-22-26
    Average 93 stars, based on 1 article reviews
    slc5a7 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher high-affinity choline transporter (slc5a7/cht1) antibody
    Figure 7. CircFBXW4 regulates <t>SLC5A7</t> expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.
    High Affinity Choline Transporter (Slc5a7/Cht1) Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/cht1+antibody/pm37827341-89-41-46
    Average 90 stars, based on 1 article reviews
    high-affinity choline transporter (slc5a7/cht1) antibody - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology vsig1
    Figure 7. CircFBXW4 regulates <t>SLC5A7</t> expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.
    Vsig1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/CHT1+Antibody/pm37587724-107-18-20
    Average 93 stars, based on 1 article reviews
    vsig1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Addgene inc human cht1-wt cdna
    Figure 7. CircFBXW4 regulates <t>SLC5A7</t> expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.
    Human Cht1 Wt Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/human+cht1+wt+cdna/pm36611016-247-1-10
    Average 90 stars, based on 1 article reviews
    human cht1-wt cdna - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-cht1 rabbit polyclonal antibody
    Figure 7. CircFBXW4 regulates <t>SLC5A7</t> expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.
    Anti Cht1 Rabbit Polyclonal Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cht1/pm36611016-271-5-19
    Average 90 stars, based on 1 article reviews
    anti-cht1 rabbit polyclonal antibody - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 1 Radioactive choline uptake assay of human CHT1 expressed in HEK293 cells. a Radioactive choline uptake of the CHT1-expressing HEK293 cells (wild-type, blue bar) as compared to the background radioactivity from the control cells transfected with the empty vector (EV, gray bar) 10 min after adding 0.1 mM choline with 10% of [3H]-choline. The inhibition of CHT1-mediated choline uptake was measured at 0.1 mM HC3 or 1 mM ML352. Data are mean ± SEM (n = 3 independent experiments). One-way ANOVA; ****P ≤0.0001. b Concentration- dependent choline uptake. Data points are mean ± SEM (n = 3 independent experiments) and fitted to the Michaelis–Menten equation with KM = 3.86 ± 0.68 mM. c Na+ and Cl–-dependent choline uptake. Data are mean ± SEM (n = 4 independent experiments) and are normalized against the radioactivity measurement with NaCl in the reaction solution. One-way ANOVA; ****P ≤0.0001. d, e Concentration-dependent inhibition of CHT1-mediated choline uptake by HC3 (d) and ML352 (e). Data points are mean ± SEM (n = 3 for HC3 and n = 3–6 for ML352) and fitted to the three-parameter dose–response curves (GraphPad Prism 9) with IC50 of 4.98 ± 1.04 nM for HC3 and 168.6 ± 49.4 nM for ML352.

    Journal: Cell discovery

    Article Title: Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1.

    doi: 10.1038/s41421-024-00731-7

    Figure Lengend Snippet: Fig. 1 Radioactive choline uptake assay of human CHT1 expressed in HEK293 cells. a Radioactive choline uptake of the CHT1-expressing HEK293 cells (wild-type, blue bar) as compared to the background radioactivity from the control cells transfected with the empty vector (EV, gray bar) 10 min after adding 0.1 mM choline with 10% of [3H]-choline. The inhibition of CHT1-mediated choline uptake was measured at 0.1 mM HC3 or 1 mM ML352. Data are mean ± SEM (n = 3 independent experiments). One-way ANOVA; ****P ≤0.0001. b Concentration- dependent choline uptake. Data points are mean ± SEM (n = 3 independent experiments) and fitted to the Michaelis–Menten equation with KM = 3.86 ± 0.68 mM. c Na+ and Cl–-dependent choline uptake. Data are mean ± SEM (n = 4 independent experiments) and are normalized against the radioactivity measurement with NaCl in the reaction solution. One-way ANOVA; ****P ≤0.0001. d, e Concentration-dependent inhibition of CHT1-mediated choline uptake by HC3 (d) and ML352 (e). Data points are mean ± SEM (n = 3 for HC3 and n = 3–6 for ML352) and fitted to the three-parameter dose–response curves (GraphPad Prism 9) with IC50 of 4.98 ± 1.04 nM for HC3 and 168.6 ± 49.4 nM for ML352.

    Article Snippet: The following primary antibodies were used for probing corresponding proteins: anti-Strep-tag mouse monoclonal antibody (IBA Lifesciences, cat# 2-1507-001, 1:10,000 dilution) for wild-type CHT1 and mutants; anti-Na+/ K+-ATPase subunit alpha-1 rabbit monoclonal antibody (Abcam, cat# ab76020, 1:10,000) for plasma membrane marker; anti-beta Actin mouse monoclonal antibody (Santa Cruz, cat# sc-69879, 1:2000 dilution) for cytosolic marker.

    Techniques: Expressing, Radioactivity, Control, Transfection, Plasmid Preparation, Inhibition, Concentration Assay

    Fig. 2 The overall structure of the apo human CHT1 in inward-open conformation. a Topology diagram of human CHT1. Segments of TM0, TMs 1–5, TMs 6–10, and TMs 11–12 are individually colored. b Side view of 3D reconstruction (left) and cartoon representation of the CHT1apo structure with the four segments individually colored as the topology diagram in a. c Bottom view of the apo CHT1 from the intracellular side. The red dashed oval marks the entrance of the intracellular vestibule. d Side view of the cross-section of the surface-rendered CHT1apo

    Journal: Cell discovery

    Article Title: Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1.

    doi: 10.1038/s41421-024-00731-7

    Figure Lengend Snippet: Fig. 2 The overall structure of the apo human CHT1 in inward-open conformation. a Topology diagram of human CHT1. Segments of TM0, TMs 1–5, TMs 6–10, and TMs 11–12 are individually colored. b Side view of 3D reconstruction (left) and cartoon representation of the CHT1apo structure with the four segments individually colored as the topology diagram in a. c Bottom view of the apo CHT1 from the intracellular side. The red dashed oval marks the entrance of the intracellular vestibule. d Side view of the cross-section of the surface-rendered CHT1apo

    Article Snippet: The following primary antibodies were used for probing corresponding proteins: anti-Strep-tag mouse monoclonal antibody (IBA Lifesciences, cat# 2-1507-001, 1:10,000 dilution) for wild-type CHT1 and mutants; anti-Na+/ K+-ATPase subunit alpha-1 rabbit monoclonal antibody (Abcam, cat# ab76020, 1:10,000) for plasma membrane marker; anti-beta Actin mouse monoclonal antibody (Santa Cruz, cat# sc-69879, 1:2000 dilution) for cytosolic marker.

    Techniques:

    Fig. 3 The substrate-bound CHT1Chol structure. a Bottom view of the CHT1Chol structure with the bound ions and choline highlighted in red dashed boxes. b Zoomed-in view of choline-binding in CHT1. The density (blue mesh) for choline is contoured at 6 σ. Key choline-interacting residues are shown in sticks. The bound Cl– and Na+ are also shown for reference. c The effect of mutagenesis at the substrate-binding site on choline uptake. Data are mean ± SEM (n = 4–6 independent experiments) and are normalized against the measurement from the wild-type CHT1. One-way ANOVA; ****P ≤0.0001. d Zoomed-in view of Cl– binding in CHT1. The density (blue mesh) for the Cl– ion is contoured at 4 σ. Key Cl–-interacting residues are shown in sticks. The dotted lines mark the coordination between the Cl– ion and the protein atoms. The inset provides an alternative view of the 63VGGGY67 region for enhanced clarity. e Zoomed-in view of Na+ binding at Na2 in CHT1. The density (blue mesh) for the Na+ ion is contoured at 4 σ. Key Na+ -interacting residues are shown in sticks. The dotted lines mark the coordination between the Na+ ion and the protein atoms. The surrounding residues for the Na3 site (red dotted circle) are also shown. f The effect of mutagenesis at Na2 and Na3 sites on choline uptake. Data are mean ± SEM (n = 3–8 independent experiments) and are normalized against the measurement from the wild-type CHT1. One-way ANOVA; ****P ≤0.0001.

    Journal: Cell discovery

    Article Title: Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1.

    doi: 10.1038/s41421-024-00731-7

    Figure Lengend Snippet: Fig. 3 The substrate-bound CHT1Chol structure. a Bottom view of the CHT1Chol structure with the bound ions and choline highlighted in red dashed boxes. b Zoomed-in view of choline-binding in CHT1. The density (blue mesh) for choline is contoured at 6 σ. Key choline-interacting residues are shown in sticks. The bound Cl– and Na+ are also shown for reference. c The effect of mutagenesis at the substrate-binding site on choline uptake. Data are mean ± SEM (n = 4–6 independent experiments) and are normalized against the measurement from the wild-type CHT1. One-way ANOVA; ****P ≤0.0001. d Zoomed-in view of Cl– binding in CHT1. The density (blue mesh) for the Cl– ion is contoured at 4 σ. Key Cl–-interacting residues are shown in sticks. The dotted lines mark the coordination between the Cl– ion and the protein atoms. The inset provides an alternative view of the 63VGGGY67 region for enhanced clarity. e Zoomed-in view of Na+ binding at Na2 in CHT1. The density (blue mesh) for the Na+ ion is contoured at 4 σ. Key Na+ -interacting residues are shown in sticks. The dotted lines mark the coordination between the Na+ ion and the protein atoms. The surrounding residues for the Na3 site (red dotted circle) are also shown. f The effect of mutagenesis at Na2 and Na3 sites on choline uptake. Data are mean ± SEM (n = 3–8 independent experiments) and are normalized against the measurement from the wild-type CHT1. One-way ANOVA; ****P ≤0.0001.

    Article Snippet: The following primary antibodies were used for probing corresponding proteins: anti-Strep-tag mouse monoclonal antibody (IBA Lifesciences, cat# 2-1507-001, 1:10,000 dilution) for wild-type CHT1 and mutants; anti-Na+/ K+-ATPase subunit alpha-1 rabbit monoclonal antibody (Abcam, cat# ab76020, 1:10,000) for plasma membrane marker; anti-beta Actin mouse monoclonal antibody (Santa Cruz, cat# sc-69879, 1:2000 dilution) for cytosolic marker.

    Techniques: Binding Assay, Mutagenesis

    Fig. 5 The structure of HC3-inhibited CHT1 in outward-open conformation. a Side view of the cross-section of the surface-rendered CHT1HC

    Journal: Cell discovery

    Article Title: Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1.

    doi: 10.1038/s41421-024-00731-7

    Figure Lengend Snippet: Fig. 5 The structure of HC3-inhibited CHT1 in outward-open conformation. a Side view of the cross-section of the surface-rendered CHT1HC

    Article Snippet: The following primary antibodies were used for probing corresponding proteins: anti-Strep-tag mouse monoclonal antibody (IBA Lifesciences, cat# 2-1507-001, 1:10,000 dilution) for wild-type CHT1 and mutants; anti-Na+/ K+-ATPase subunit alpha-1 rabbit monoclonal antibody (Abcam, cat# ab76020, 1:10,000) for plasma membrane marker; anti-beta Actin mouse monoclonal antibody (Santa Cruz, cat# sc-69879, 1:2000 dilution) for cytosolic marker.

    Techniques:

    Fig. 6 The structure of ML352-inhibited CHT1 in inward-open conformation. a The structure of CHT1ML with the bound ML352 inhibitor on the external surface of the transporter. The zoomed-in view of the surface-rendered CHT1ML illustrates the space-filling binding of ML352. Cryo-EM density of ML352 in the contour level of 0.42 in ChimeraX. b Structural comparison between CHT1apo and CHT1ML illustrates subtle structural change at the EL6 loop between the two. c Zoomed-in view of the protein–inhibitor interactions.

    Journal: Cell discovery

    Article Title: Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1.

    doi: 10.1038/s41421-024-00731-7

    Figure Lengend Snippet: Fig. 6 The structure of ML352-inhibited CHT1 in inward-open conformation. a The structure of CHT1ML with the bound ML352 inhibitor on the external surface of the transporter. The zoomed-in view of the surface-rendered CHT1ML illustrates the space-filling binding of ML352. Cryo-EM density of ML352 in the contour level of 0.42 in ChimeraX. b Structural comparison between CHT1apo and CHT1ML illustrates subtle structural change at the EL6 loop between the two. c Zoomed-in view of the protein–inhibitor interactions.

    Article Snippet: The following primary antibodies were used for probing corresponding proteins: anti-Strep-tag mouse monoclonal antibody (IBA Lifesciences, cat# 2-1507-001, 1:10,000 dilution) for wild-type CHT1 and mutants; anti-Na+/ K+-ATPase subunit alpha-1 rabbit monoclonal antibody (Abcam, cat# ab76020, 1:10,000) for plasma membrane marker; anti-beta Actin mouse monoclonal antibody (Santa Cruz, cat# sc-69879, 1:2000 dilution) for cytosolic marker.

    Techniques: Binding Assay, Cryo-EM Sample Prep, Comparison

    Fig. 7 A working model for the Na+ and Cl–-dependent choline transport in CHT1. The orange arrows mark the conformational changes driven by the choline-binding from the extracellular side.

    Journal: Cell discovery

    Article Title: Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1.

    doi: 10.1038/s41421-024-00731-7

    Figure Lengend Snippet: Fig. 7 A working model for the Na+ and Cl–-dependent choline transport in CHT1. The orange arrows mark the conformational changes driven by the choline-binding from the extracellular side.

    Article Snippet: The following primary antibodies were used for probing corresponding proteins: anti-Strep-tag mouse monoclonal antibody (IBA Lifesciences, cat# 2-1507-001, 1:10,000 dilution) for wild-type CHT1 and mutants; anti-Na+/ K+-ATPase subunit alpha-1 rabbit monoclonal antibody (Abcam, cat# ab76020, 1:10,000) for plasma membrane marker; anti-beta Actin mouse monoclonal antibody (Santa Cruz, cat# sc-69879, 1:2000 dilution) for cytosolic marker.

    Techniques: Binding Assay

    The expression levels of cholinergic‐related proteins in the basal forebrain and hippocampus. (A–E) The expression levels of vAchT (A), ChT1 (B), AchE (C), m1AchR (D), and m2AchR (E) in the basal forebrain after EA intervention. (F‐J) The expression levels of vAchT (F), ChT1 (G), AchE (H), m1AchR (I), and m2AchR (J) in the hippocampus after EA intervention ( n = 6 for each group, ** p < 0.01/*** p < 0.001 vs WT group, # p < 0.05/## p < 0.01/### p < 0.001 vs AD group, && p < 0.01 vs EA group). (K) Greyscale image of proteins. vAchT, vesicular acetylcholine transporter; ChT1, Choline transporter; AchE, enzyme acetylcholinesterase; m1AchR, Type‐1 muscarinic Acetylcholine receptor; m2AchR, Type‐2 muscarinic Acetylcholine receptor.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: Electroacupuncture regulates Rab5a‐mediating NGF transduction to improve learning and memory ability in the early stage of AD mice

    doi: 10.1111/cns.14743

    Figure Lengend Snippet: The expression levels of cholinergic‐related proteins in the basal forebrain and hippocampus. (A–E) The expression levels of vAchT (A), ChT1 (B), AchE (C), m1AchR (D), and m2AchR (E) in the basal forebrain after EA intervention. (F‐J) The expression levels of vAchT (F), ChT1 (G), AchE (H), m1AchR (I), and m2AchR (J) in the hippocampus after EA intervention ( n = 6 for each group, ** p < 0.01/*** p < 0.001 vs WT group, # p < 0.05/## p < 0.01/### p < 0.001 vs AD group, && p < 0.01 vs EA group). (K) Greyscale image of proteins. vAchT, vesicular acetylcholine transporter; ChT1, Choline transporter; AchE, enzyme acetylcholinesterase; m1AchR, Type‐1 muscarinic Acetylcholine receptor; m2AchR, Type‐2 muscarinic Acetylcholine receptor.

    Article Snippet: The membranes were incubated with primary antibodies at 4°C: Rab5a (1:1000; 24 h, CST, E6N8S); Rabep1 (1:5000; 24 h, Abcam, ab176578); TrkA (1:300; 36 h, Abcam, ab216626); pTrkA (1:500; 36 h, Invitrogen, PA5‐37672); AKT (1:1000; 24 h, CST, #4691); pAKT (1:1000; 36 h, CST, #4060); ERK (1:5000; 24 h, Abcam, ab184699); pERK (1:2000; 24 h, CST, #4370); ChAT (1:5000; 24 h, Abcam, ab181023); AchE (1:5000; 36 h, Abcam, ab183591); vAchT (1:1000; 36 h, Sigma, sab4200559); ChT1 (1:5000; 24 h, Abcam, ab154186); m1AchR (1:1000; 36 h, boster, BA1543); m2AchR (1:5000; 24 h, Abcam, ab109226); GAPDH (1:5000; 24 h, Proteintech, 60,004–1‐1 g); and β‐actin (1:5000; 24 h, Proteintech, 66,009–1‐1 g).

    Techniques: Expressing

    Figure 7. CircFBXW4 regulates SLC5A7 expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.

    Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Article Title: CircFBXW4 Suppresses Colorectal Cancer Progression by Regulating the MiR-338-5p/SLC5A7 Axis.

    doi: 10.1002/advs.202300129

    Figure Lengend Snippet: Figure 7. CircFBXW4 regulates SLC5A7 expression by acting as a sponge for miR-338-5p. A) Relative expression of candidate mRNAs in SW480 cells transfected with the miR-338-5p mimic. B) Relative expression of candidate mRNAs in SW620 cells transfected with the miR-338-5p inhibitor. C) Relative protein levels of SLC5A7 in CRC cells transfected with the miR-338-5p mimic or inhibitor. D) The relative expression of SLC5A7 in CRC tissues and matched adjacent normal tissues was determined by qRT‒PCR (n = 40). E) Pearson correlation analysis between the expression levels of miR-338-5p and SLC5A7 in our own patient cohort (n = 40). F) Schematic illustration of the SLC5A7-WT and SLC5A7-MUT luciferase reporter vectors. G) Relative luciferase activity was measured in 293T cells after cotransfection with SLC5A7-WT or SLC5A7-MUT and the miR-338-5p mimic or NC. H) The relative mRNA and protein expression levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW480 cells transfected with si-NC or si-circFBXW4 with or without the miR-338-5p inhibitor. I) The relative mRNA and protein levels of SLC5A7 were measured by qRT‒PCR and western blotting in SW620 cells transfected with vector or the circFBXW4-OE plasmid with or without the miR-338-5p mimic. The data are shown as the means ± SDs; *P < 0.05, **P < 0.01, ***P < 0.001.

    Article Snippet: The primary antibodies used to detect Ki-67, PCNA, and Caspase3 were purchased from ABclonal (China), and the primary antibody used to detect SLC5A7 was purchased from ProteinTech (China).

    Techniques: Expressing, Transfection, Luciferase, Activity Assay, Cotransfection, Western Blot, Plasmid Preparation